Example: Heart Attack

Search clinical trials for: Glutamine

Total 220 results

    • NCT04684381
      Recruiting
      Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients
      Conditions: Sickle Cell Disease; Pharmacokinetics
    • NCT03947879
      Not yet recruiting
      The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II
      Conditions: Diabetes Mellitus, Type 2
    • NCT03113240
      Completed
      Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients
      Conditions: Critical Illness; Enteral Nutrition; Intestinal Permeability
    • NCT02215083
      Withdrawn
      L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
      Conditions: Peripheral Neuropathy
    • NCT01414244
      Completed
      Glutamine for the Treatment of Patients With Irritable Bowel Syndrome
      Conditions: Diarrhea-Predominant Irritable Bowel Syndrome
    • NCT02998931
      Completed
      Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients
      Conditions: Critical Illness; Enteral Nutrition; Multiple Organ Failure; Infection Complication; Inflammation
    • NCT02024191
      Unknown status
      The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy
      Conditions: Peripheral Neuropathy
    • NCT01157039
      Withdrawn
      A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin
      Conditions: Colorectal Carcinoma; Neoplasms, Colorectal; Colorectal Cancer; Colorectal Tumors; Metastasis
    • NCT01704430
      Completed
      Glutamine to Improve Outcomes in Cardiac Surgery
      Conditions: Nosocomial Infection
    • NCT04634539
      Not yet recruiting
      Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer
      Conditions: Advanced Pancreatic Adenocarcinoma; Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma
    • NCT02053350
      Terminated
      Efficacy Study of Alanyl-glutamine Supplementation for the Treatment of C. Difficile Infection
      Conditions: Clostridium Difficile Infection
    • NCT02838979
      Unknown status
      Trial of Oral Glutamine on Mitochondrial Function in CKD
      Conditions: Cardiovascular Disease; Sarcopenia; Endothelial Dysfunction; Muscle Mitochondrial Function; Kidney Disease
    • NCT01794884
      Completed
      Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery
      Conditions: Rheumatic Heart Disease; Coronary Heart Disease
    • NCT01798342
      Completed
      Safety of Gastric Volume Emptying After the Intake of Maltodextrin and Glutamine
      Conditions: Pulmonary Aspiration of Gastric Contents; Adverse Effects in the Therapeutic Use of Other and Unspecified General Anaesthetics; Pulmonary Aspiration During Anaesthetic Induction
    • NCT00922714
      Terminated
      Scandinavian Intensive Care Unit (ICU) Glutamine Study
      Conditions: ICU Patients
    • NCT04305769
      Not yet recruiting
      Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
      Conditions: Clostridioides Difficile Infection; Clostridium Difficile Infection; Clostridium Difficile Diarrhea; Clostridia Difficile Colitis
    • NCT03048994
      Completed
      Glutamine Supplementation in Critically Ill Patients With Severe Sepsis
      Conditions: Severe Sepsis
    • NCT02738762
      Withdrawn
      Glutamine Supplementation
      Conditions: Glutamine; Length of Stay; Mechanical Ventilation
    • NCT01478126
      Completed
      Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass
      Conditions: Coronary Artery Disease
    • NCT01367223
      Completed
      Modulation of Systemic Inflammatory Response in Critically Ill Children After Glutamine Supplementation
      Conditions: Inflammatory Response; Multi-organ Failure
    • NCT01051999
      Completed
      Glutamine Supplementation in Cystic Fibrosis
      Conditions: Cystic Fibrosis; Immune Function
    • NCT00838149
      Completed
      Effect of Glutamine on Intestinal Permeability in Crohn's Disease
      Conditions: Crohn's Disease
    • NCT03166956
      Completed
      Effect of Glutamine and Vitamin C on Interleukin-6 and Clinical Outcomes in Surgical Intensive Care Unit Patients
      Conditions: Critical Care
    • NCT02012608
      Terminated
      Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
      Conditions: Breast Cancer
    • NCT01179217
      Completed
      A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
      Conditions: Sickle Cell Anemia; Sickle ß0-Thalassemia
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations